Cercar
01/03/2024
Loss of Expression of ARID1a and PBRM1 Proteins Is Associated with Poor Prognosis in Mullerian Adenosarcomas
Espinosa, I, D'Angelo, E, Gallardo, A, Lee, CH, Koebel, M, Prat, J. Loss of Expression of ARID1a and PBRM1 Proteins Is Associated with Poor Prognosis in Mullerian Adenosarcomas. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).
01/03/2024
Tumor Microenvironment in Dedifferentiated and Undifferentiated Endometrial Carcinomas: The Emerging Role of Spatial Cancer-Immunophenotypes and HLA Class I Expression
De Leo, A, Ceccarelli, C, Grillini, M, de Biase, D, Tallini, G, Espinosa, I, Koebel, M, Lee, CH. Tumor Microenvironment in Dedifferentiated and Undifferentiated Endometrial Carcinomas: The Emerging Role of Spatial Cancer-Immunophenotypes and HLA Class I Expression. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).
10/08/2023
Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins
Álamo P., Parladé E., Favaro, MTP, Gallardo A., Mendoza R., Ferreira, LCS, Roher N., Mangues R., Villaverde A., Vázquez E.. Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins. ACS Applied Materials & Interfaces. 2023; 15(33)DOI:10.1021/acsami.3c08643. PMID:37614001. IF:8.500(Q1/2D).
01/07/2023
Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study
Marti-Aguado, D, Gougol, A, Gomez-Medina, C, Jamali, A, Abo-Zed, A, Morales-Arraez, D, Jimenez-Sosa, A, Burns, K, Bawa, A, Hernandez, A, Pujol, C, Alvarado-Tapias, E, Szafranska, J, Chiu, WK, Villagrasa, A, Ventura-Cots, M, Gandicheruvu, H, Lluch, P, Chen, HW, Rachakonda, V, Duarte-Rojo, A, Bataller, R. Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study. Eclinicalmedicine. 2023; 61DOI:10.1016/j.eclinm.2023.102046. PMID:37415844. IF:9.600(Q1/1D).
28/06/2023
Sarcomatoid transformation of a basal cell carcinoma following treatment with hedgehog inhibitors
Barrabes-Torrella, C, Arandes-Marcocci, J, Armillas-Lliteras, L, Posada-Caez, RA, Koptseva, I, Fumagalli, C, Pinol-Ballus, D, Salleras-Redonnet, M. Sarcomatoid transformation of a basal cell carcinoma following treatment with hedgehog inhibitors. BRITISH JOURNAL OF DERMATOLOGY. 2023; 189(4)DOI:10.1093/bjd/ljad206. PMID:37378960. IF:11.000(Q1/1D).
01/06/2023
Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets
Barca, EG, Tomas-Roca, L, Esteve, A, Rodriguez, M, Gato, L, Alonso-Alonso, R, Garcia-Sancho, AM, Cordoba, R, Monter-Rovira, A, Bastos-Oreiro, M, Burgues, JMB, Sayas, MJ, Alegria, MCV, Sanchez-Blanco, JJ, Pellicer, MR, Henriquez, HDL, de Ona, R, Cabezudo, ME, Infante, MS, Hernandez, JAQ, Sanz-Pamplona, R, Blanco, O, Mozos, A, Climent, F, Piris, MA. Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets. AMERICAN JOURNAL OF HEMATOLOGY. 2023; 98(6)DOI:10.1002/ajh.26904. PMID:36882876. IF:10.100(Q1/1D).